Key Metrics
MARKET CAP
$19.92B
P/E RATIO
15.6
BETA
0.85
Less volatile
DIV YIELD
N/A
52W HIGH
$112.29
52W LOW
$53.56
VOLATILITY
39.2%
30d annualized
Price Performance
30-DAY PRICE CHART
$103.47 → $100.09-3.27%
30 days agoToday
1-YEAR PERFORMANCE
$73.50 → $100.09+36.2%
INCY | 52-week chartLast updated: 2/27/2026
Healthcare Sector Context
Competitors Analysis
Technical Analysis
Incyte Corporation is currently trading at $100.09, which is 10.9% below its 52-week high. With a beta of 0.85, the stock shows average sensitivity to market movements.
RSI (14)OVERSOLD
30-DAY TRENDNEUTRAL
VOLUME2.1M(Above avg)
Frequently Asked Questions
Is INCY a good buy right now?
Incyte Corporation trades at 15.6x earnings. This is near market average. Current risk level is High based on 39.2% volatility.
Does INCY pay dividends?
Incyte Corporation does not currently pay a regular dividend. The company may be reinvesting profits for growth.
How volatile is INCY?
With 30-day annualized volatility of 39.2% and beta of 0.85,INCY is classified as High risk. The stock tends to be more stable than the market average.
Related Assets
LLYANALYZE →
Eli Lilly and Company
NVOANALYZE →
Novo Nordisk A/S
UNHANALYZE →
UnitedHealth Group
JNJANALYZE →
Johnson & Johnson
ABBVANALYZE →
AbbVie Inc.
Track INCY Live
Add Incyte Corporation to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALLast updated: 2/27/2026, 2:03:58 PM